Back

The emerging promise of GLP-1 receptor agonists

12 April 2026 (14:15 - 14:30)
Organised by: Logo
Congress Presentation Part of: Pharmacological treatment for atrial fibrillation Arrhythmias, General EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Valeria Caso

Hospital Santa Maria Della Misericordia, Perugia (Italy)

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors: a new era in atrial fibrillation prevention?
Professor D. Linz (Maastricht, NL)
Slides
Presentation thumbnail
Antifibrotic drugs: the journey to prime time
Doctor S. Matsumoto (Tokyo, JP)
Slides
Presentation thumbnail
Anti-hypertensive agents: is there a benefit beyond lowering blood pressure?
Professor M. Rienstra (Groningen, NL)
Slides

Access the full session

Session thumbnail
Pharmacological treatment for atrial fibrillation

The Event

Event poster

EHRA 2026

12 April 2026 14:15 CET
You may be interested in
thumbnail
Webinar
GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?
24 November 2025
thumbnail
Congress Presentation
Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study
31 August 2024
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on blood pressure: a systematic review and meta-analysis
4 April 2025
thumbnail
Congress Presentation
GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources